TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

shantanu narayen

T3 · host / generalist

Shantanu Narayen has been CEO of Adobe since 2007 and Chair since 2019. He led Adobe's transition to cloud subscription model, built the $5B+ Experience Cloud digital marketing business, and serves on the board of Pfizer. He grew up in Hyderabad, India, and holds an MBA from UC Berkeley.

3 calls·3 names·100% bull·last heard 2 years ago·In Good Company with Nicolai Tangen
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1stmedium conviction
$KKRKKR

Narayen adopts George Roberts' 'invest not risk' philosophy for capital allocation

Narayen credits KKR founder George Roberts for teaching him to frame capital allocation as 'investments' rather than 'risks,' emphasizing that executives are paid to put money to work with a better-than-even track record, a mindset he applies at Adobe.

In Good Company with Nicolai Tangen2024-06episode →
2ndmedium conviction
$PFEPfizer

Narayen praises Pfizer's moonshot COVID vaccine as model of long-term R&D

As a Pfizer board member, Narayen highlights the company's willingness to pursue unreasonable expectations like the COVID vaccine moonshot, where medicinal bets often have such long timelines that successors reap the benefits, demonstrating the value of long-range pharmaceutical R&D.

In Good Company with Nicolai Tangen2024-06episode →
3rdlow conviction
$LLYEli Lilly

Narayen cites Eli Lilly CEO Dave Ricks as exemplary board addition

Narayen points to Eli Lilly CEO Dave Ricks joining Adobe's board as evidence of recruiting high-caliber leaders who have created tremendous value, implying confidence in Lilly's execution under Ricks.

In Good Company with Nicolai Tangen2024-06episode →

most discussed · click a bar to filter

  • $KKR
  • $LLY
  • $PFE

recurring themes

  • AI Infrastructure1
  • Cybersecurity1
  • Enterprise Software1
  • AI Geopolitics & Export Controls1
  • Private Markets1
3 total
$KKR
···
KKR
MEDshantanu narayen·In Good Company with Nicolai Tangen·2 years ago·Shantanu Narayen - CEO of Adobe | Podcast | In Good Company | Norges Bank Investment Management
Narayen adopts George Roberts' 'invest not risk' philosophy for capital allocation
Narayen credits KKR founder George Roberts for teaching him to frame capital allocation as 'investments' rather than 'risks,' emphasizing that executives are paid to put money to work with a better-than-even track record, a mindset he applies at Adobe.
"George Roberts uh you know the founder of KKR uh I'm fortunate enough to have got to know George Roberts really well and you know the advice that he gives and to see you know the…"
41:44
$LLY
···
Eli Lilly
LOWshantanu narayen·In Good Company with Nicolai Tangen·2 years ago·Shantanu Narayen - CEO of Adobe | Podcast | In Good Company | Norges Bank Investment Management
Narayen cites Eli Lilly CEO Dave Ricks as exemplary board addition
Narayen points to Eli Lilly CEO Dave Ricks joining Adobe's board as evidence of recruiting high-caliber leaders who have created tremendous value, implying confidence in Lilly's execution under Ricks.
"are the people on the board people whom you would look at and say hey are these people who have uh you know created uh tremendous value and are they going to be people who are jus…"
45:45
$PFE
···
Pfizer
MEDshantanu narayen·In Good Company with Nicolai Tangen·2 years ago·Shantanu Narayen - CEO of Adobe | Podcast | In Good Company | Norges Bank Investment Management
Narayen praises Pfizer's moonshot COVID vaccine as model of long-term R&D
As a Pfizer board member, Narayen highlights the company's willingness to pursue unreasonable expectations like the COVID vaccine moonshot, where medicinal bets often have such long timelines that successors reap the benefits, demonstrating the value of long-range pharmaceutical R&D.
"well uh you know talk about unreasonable expectations you know when Albert talked about moonshots and solving Co right I mean they that was an unreasonable expectation that was a…"
43:33
9
AI Infrastructuretailwind
Generative AI is a massive tailwind expanding creative software TAM
Narayen argues every major technology shift (cloud, mobile, AI) expands Adobe's addressable market; generative AI eliminates the 'blank page' problem, automates mundane tasks, and enables conversational interfaces, driving dramatic growth in creative activity volume. Adobe's three-layer strategy (interface, foundation models, data) with Firefly models trained on licensed data and indemnification creates a defensible moat.
8
Cybersecuritytailwind
Content Credentials initiative builds digital provenance infrastructure against deepfakes
Adobe leads the Content Authenticity Initiative with thousands of partners (camera makers, Meta, NYT, BBC) embedding cryptographic provenance metadata from capture through edit to distribution. The technology plumbing exists, but consumer adoption of 'nutrition labels' for content remains the key challenge, especially during election cycles where 50% of global population votes.
7
Enterprise Softwaretailwind
Experience Cloud built from scratch into $5B+ digital experience platform
Adobe identified unmet need for marketing automation when moving to direct customer engagement, acquired Omniture and Day Software, built real-time CDP organically, and now uses AI to deliver personalized website experiences at scale. This demonstrates successful platform extension from creative tools into enterprise marketing stack.
7
AI Geopolitics & Export Controlstailwind
India's tech ecosystem maturing with reverse talent migration and global ambitions
Narayen observes Indian entrepreneurs now have global aspirations with access to capital and talent locally, reversing the historical brain drain to the US. He warns against post-COVID protectionism fragmenting global talent flows, highlighting India's infrastructure and education investments as drivers of a worldwide technology phenomenon.
6
Private Marketsrisk
Long-horizon medicinal bets require investor patience beyond typical fund cycles
From Pfizer board experience, Narayen notes pharmaceutical moonshots like COVID vaccines have such long development timelines that successors often reap the rewards, illustrating a structural mismatch between venture/private equity fund lifespans and deep tech/biotech innovation cycles.